Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy.

You Y, Perkins A, Cisternas P, Muñoz B, Taylor X, You Y, Garringer HJ, Oblak AL, Atwood BK, Vidal R, Lasagna-Reeves CA.

Acta Neuropathol Commun. 2019 Feb 26;7(1):26. doi: 10.1186/s40478-019-0680-z.


Alcohol exposure disrupts mu opioid receptor-mediated long-term depression at insular cortex inputs to dorsolateral striatum.

Muñoz B, Fritz BM, Yin F, Atwood BK.

Nat Commun. 2018 Apr 3;9(1):1318. doi: 10.1038/s41467-018-03683-1.


A High-fat, High-sugar 'Western' Diet Alters Dorsal Striatal Glutamate, Opioid, and Dopamine Transmission in Mice.

Fritz BM, Muñoz B, Yin F, Bauchle C, Atwood BK.

Neuroscience. 2018 Feb 21;372:1-15. doi: 10.1016/j.neuroscience.2017.12.036. Epub 2017 Dec 28.


Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens.

Mateo Y, Johnson KA, Covey DP, Atwood BK, Wang HL, Zhang S, Gildish I, Cachope R, Bellocchio L, Guzmán M, Morales M, Cheer JF, Lovinger DM.

Neuron. 2017 Dec 6;96(5):1112-1126.e5. doi: 10.1016/j.neuron.2017.11.012.


Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation.

Gremel CM, Chancey JH, Atwood BK, Luo G, Neve R, Ramakrishnan C, Deisseroth K, Lovinger DM, Costa RM.

Neuron. 2016 Jun 15;90(6):1312-1324. doi: 10.1016/j.neuron.2016.04.043. Epub 2016 May 26.


Presynaptic long-term depression mediated by Gi/o-coupled receptors.

Atwood BK, Lovinger DM, Mathur BN.

Trends Neurosci. 2014 Nov;37(11):663-73. doi: 10.1016/j.tins.2014.07.010. Epub 2014 Aug 24. Review.


Opioids induce dissociable forms of long-term depression of excitatory inputs to the dorsal striatum.

Atwood BK, Kupferschmidt DA, Lovinger DM.

Nat Neurosci. 2014 Apr;17(4):540-8. doi: 10.1038/nn.3652. Epub 2014 Feb 23.


CB₂ cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons.

Atwood BK, Straiker A, Mackie K.

Neuropharmacology. 2012 Sep;63(4):514-23. doi: 10.1016/j.neuropharm.2012.04.024. Epub 2012 May 8.


CB₂: therapeutic target-in-waiting.

Atwood BK, Straiker A, Mackie K.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jul 2;38(1):16-20. doi: 10.1016/j.pnpbp.2011.12.001. Epub 2011 Dec 9. Review.


Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands.

Atwood BK, Wager-Miller J, Haskins C, Straiker A, Mackie K.

Mol Pharmacol. 2012 Feb;81(2):250-63. doi: 10.1124/mol.111.074013. Epub 2011 Nov 7.


CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists.

Atwood BK, Lee D, Straiker A, Widlanski TS, Mackie K.

Eur J Pharmacol. 2011 Jun 1;659(2-3):139-45. doi: 10.1016/j.ejphar.2011.01.066. Epub 2011 Feb 16.


Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis.

Atwood BK, Lopez J, Wager-Miller J, Mackie K, Straiker A.

BMC Genomics. 2011 Jan 7;12:14. doi: 10.1186/1471-2164-12-14.


CB2: a cannabinoid receptor with an identity crisis.

Atwood BK, Mackie K.

Br J Pharmacol. 2010 Jun;160(3):467-79. doi: 10.1111/j.1476-5381.2010.00729.x. Review.


JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist.

Atwood BK, Huffman J, Straiker A, Mackie K.

Br J Pharmacol. 2010 Jun;160(3):585-93. doi: 10.1111/j.1476-5381.2009.00582.x. Epub 2010 Jan 22.

Supplemental Content

Loading ...
Support Center